As of May 27, 2025, Shockwave Medical Inc (SWAV) reports a ROE (Return on Equity) of 22.03%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Shockwave Medical Inc's ROE (Return on Equity)
Over recent years, Shockwave Medical Inc's ROE (Return on Equity) has shown a stable trend. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2023-12-31 | 22.03% |
| 2022-12-31 | 42.25% |
| 2021-12-31 | -3.76% |
| 2020-12-31 | -29.11% |
| 2019-12-31 | -26.52% |
This fluctuation highlights how Shockwave Medical Inc manages its efficiency in generating profits from shareholders' equity over time.
Comparing Shockwave Medical Inc's ROE (Return on Equity) to Peers
To better understand Shockwave Medical Inc's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Shockwave Medical Inc (SWAV) | 22.03% |
| Intersect Ent Inc (XENT) | 231.11% |
| IDEXX Laboratories Inc (IDXX) | 55.65% |
| Edwards Lifesciences Corp (EW) | 41.75% |
| Abbott Laboratories (ABT) | 28.12% |
| Dexcom Inc (DXCM) | 27.40% |
Compared to its competitors, Shockwave Medical Inc's ROE (Return on Equity) is among the highest compared to peers, suggesting efficient use of shareholder equity to generate profits.